Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T
- 1 July 1996
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 36 (1) , 72-77
- https://doi.org/10.1002/mrm.1910360113
Abstract
The authors report on high‐field (4.1 T) magnetic resonance 1H spectroscopic imaging studies on eight patients with relapsing remitting multiple sclerosis (mean expanded disability status scale (EDSS) 1.0) and eight normal controls. Using T1 weighted imaging to determine lesion position, the authors found the ratios of choline/N‐acetyl (NA) compounds and creatine/NA were increased significantly in the multiple sclerosis (MS) patients relative to controls in lesioned tissue, adjacent to lesion, far removed from lesions as well as in periventricular tissue. The gray matter creatine/NA was mildly increased (P < 0.01) in the MS patients, whereas the elevated gray‐matter ratio of choline/NA was of borderline significance (P = 0.13). A more detailed comparison of white‐matter and mean graymatter metabolite values indicates that creatine is increased greatest in areas far from lesions. This is in contrast to choline, which was greatest in lesions, and NA, which was smallest in lesions. It is postulated that the creatine increase may reflect an astrocytic (gliotic) or oligodendrocytic remyelinating process. The increased choline most likely reflects varying levels of inflammation and membrane turnover, whereas the NA decrease is representative of axonal dysfunction or loss.Keywords
This publication has 23 references indexed in Scilit:
- 2D 1H spectroscopic imaging of the human brain at 4.1 TMagnetic Resonance in Medicine, 1994
- High frequency volume coils for clinical NMR imaging and spectroscopyMagnetic Resonance in Medicine, 1994
- Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imagingAnnals of Neurology, 1994
- Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosisAnnals of Neurology, 1994
- Periventricular Plaques in Multiple Sclerosis: Irreversible?European Neurology, 1992
- Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosisMagnetic Resonance in Medicine, 1991
- Determination of metabolite and nucleotide concentrations in proliferating lymphocytes by 1H-NMR of acid extractsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of diseaseMagnetic Resonance in Medicine, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983